Perceptive Advisors LLC Verona Pharma PLC Put Options Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
Put Options
1 transactions
Others Institutions Holding VRNA
# of Institutions
172Shares Held
68.6MCall Options Held
704KPut Options Held
685K-
Nea Management Company, LLC Timonium, MD5.58MShares$321 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$288 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$243 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$204 Million14.95% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$195 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.51B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...